{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:09:36Z","timestamp":1751429376337,"version":"3.41.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82360295 and 82060276"],"award-info":[{"award-number":["82360295 and 82060276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Doctor Start-up Fund of Affiliated Hospital of Guizhou Medical University","award":["gyfybsky-2023-03"],"award-info":[{"award-number":["gyfybsky-2023-03"]}]},{"name":"the Science and Technology Department of Guizhou Province","award":["QianKeHeJiChu-ZK[2021]YiBan382"],"award-info":[{"award-number":["QianKeHeJiChu-ZK[2021]YiBan382"]}]},{"name":"the Science and Technology Foundation Project of Guizhou Provincial Health Commission","award":["gzwkj2024-150"],"award-info":[{"award-number":["gzwkj2024-150"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03046-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:24:30Z","timestamp":1751361870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The mediating factors between systemic lupus erythematosus and prostate cancer risk: a two-step Mendelian randomization and transcriptome analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Siwen","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quliang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuewei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3046_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024 [published correction appears in CA Cancer J Clin. 2024 Mar-Apr;74(2):203. doi: 10.3322\/caac.21830]. CA Cancer J Clin. 2024;74(1):12\u201349.","DOI":"10.3322\/caac.21820"},{"issue":"2","key":"3046_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al. 2022 update on prostate Cancer epidemiology and risk Factors-A systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"12","key":"3046_CR3","doi-asserted-by":"publisher","first-page":"a030361","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate Cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"3046_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the Immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716\u201330.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"3046_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82(8):999\u20131014.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3046_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-017-0457-4","volume":"10","author":"K Mehta","year":"2017","unstructured":"Mehta K, Patel K, Parikh RA. Immunotherapy in genitourinary malignancies. J Hematol Oncol. 2017;10(1):95.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3046_CR7","doi-asserted-by":"publisher","first-page":"11755","DOI":"10.1038\/s41598-024-62716-6","volume":"14","author":"X Deng","year":"2024","unstructured":"Deng X, Sun S, Yao W, et al. The association between three prevalent autoimmune disorders and the likelihood of developing prostate cancer: a Mendelian randomization study. Sci Rep. 2024;14(1):11755.","journal-title":"Sci Rep"},{"issue":"12","key":"3046_CR8","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1007\/s00432-023-04853-5","volume":"149","author":"J Ou","year":"2023","unstructured":"Ou J, Zhen K, Wu Y, et al. Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis. J Cancer Res Clin Oncol. 2023;149(12):9517\u201328.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3046_CR9","doi-asserted-by":"publisher","first-page":"1164679","DOI":"10.3389\/fendo.2023.1164679","volume":"14","author":"D Wu","year":"2023","unstructured":"Wu D, Ye L, Zhang X, Yin M, Guo Y, Zhou J. Characteristics of steroid hormones in systemic lupus erythematosus revealed by GC\/MS-based metabolic profiling. Front Endocrinol (Lausanne). 2023;14:1164679.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"3046_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, Morris DL, Graham DSC, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47(12):1457\u201364.","journal-title":"Nat Genet"},{"issue":"3","key":"3046_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bbrc.2018.01.139","volume":"496","author":"Z Rattray","year":"2018","unstructured":"Rattray Z, Dubljevic V, Rattray NJW, et al. Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications. Biochem Biophys Res Commun. 2018;496(3):858\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"157","key":"3046_CR12","doi-asserted-by":"publisher","first-page":"157ra142","DOI":"10.1126\/scitranslmed.3004385","volume":"4","author":"JE Hansen","year":"2012","unstructured":"Hansen JE, Chan G, Liu Y, et al. Targeting cancer with a lupus autoantibody. Sci Transl Med. 2012;4(157):157ra142.","journal-title":"Sci Transl Med"},{"issue":"10","key":"3046_CR13","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","volume":"53","author":"S Sakaue","year":"2021","unstructured":"Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415\u201324.","journal-title":"Nat Genet"},{"key":"3046_CR14","doi-asserted-by":"publisher","unstructured":"Schumacher FR, Al Olama AA, Berndt SI et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci [published correction appears in Nat Genet. 2019;51(2):363. https:\/\/doi.org\/10.1038\/s41588-018-0330-6]. Nat Genet. 2018;50(7):928\u2013936.","DOI":"10.1038\/s41588-018-0330-6]"},{"issue":"7944","key":"3046_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population [published correction appears in Nature. 2023;615(7952):E19. https:\/\/doi.org\/10.1038\/s41586-023-05837-8]. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature."},{"issue":"2","key":"3046_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","volume":"26","author":"KS Ruth","year":"2020","unstructured":"Ruth KS, Day FR, Tyrrell J, et al. Using human genetics to understand the disease impacts of testosterone in men and women. Nat Med. 2020;26(2):252\u20138.","journal-title":"Nat Med"},{"issue":"10","key":"3046_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy [published correction appears in\u00a0Nat Genet. 2020;52(11):1266. https:\/\/doi.org\/10.1038\/s41588-020-00718-6. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet."},{"issue":"8","key":"3046_CR18","doi-asserted-by":"publisher","first-page":"e1009238","DOI":"10.1371\/journal.pcbi.1009238","volume":"17","author":"SA Gagliano Taliun","year":"2021","unstructured":"Gagliano Taliun SA, Evans DM. Ten simple rules for conducting a Mendelian randomization study. PLoS Comput Biol. 2021;17(8):e1009238.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"3046_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3046_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12672-025-02530-2","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Zhang Y. Mendelian randomization analysis of immune cell traits and their association with cervical cancer risk. Discov Oncol. 2025;16(1):709.","journal-title":"Discov Oncol"},{"key":"3046_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186.","journal-title":"Wellcome Open Res"},{"issue":"2","key":"3046_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyu176","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Daniel RM, Butterworth AS, et al. EPIC-InterAct consortium. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2015;44(2):484\u201395.","journal-title":"Int J Epidemiol"},{"key":"3046_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","volume":"37","author":"TJ VanderWeele","year":"2016","unstructured":"VanderWeele TJ. Mediation analysis: A practitioner\u2019s guide. Annu Rev Public Health. 2016;37:17\u201332.","journal-title":"Annu Rev Public Health"},{"key":"3046_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.","journal-title":"BMC Bioinform"},{"issue":"1","key":"3046_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41467-018-03371-0","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zeng J, Zhang F, et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat Commun. 2018;9(1):918.","journal-title":"Nat Commun"},{"issue":"5","key":"3046_CR26","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383.","journal-title":"PLoS Genet"},{"issue":"1","key":"3046_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/jama.2021.20356","volume":"327","author":"L Bastarache","year":"2022","unstructured":"Bastarache L, Denny JC, Roden DM. Phenome-Wide association studies. JAMA. 2022;327(1):75\u20136.","journal-title":"JAMA"},{"issue":"6","key":"3046_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","volume":"51","author":"AE Clarke","year":"2021","unstructured":"Clarke AE, Pooley N, Marjenberg Z, et al. Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis. Semin Arthritis Rheum. 2021;51(6):1230\u201341.","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"3046_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/acr.24068","volume":"72","author":"T Cobo-Ib\u00e1\u00f1ez","year":"2020","unstructured":"Cobo-Ib\u00e1\u00f1ez T, Urruticoechea-Arana A, R\u00faa-Figueroa I, et al. Hormonal dependence and Cancer in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2020;72(2):216\u201324.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"3046_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41391-018-0081-6","volume":"22","author":"RW Dobbs","year":"2019","unstructured":"Dobbs RW, Malhotra NR, Greenwald DT, Wang AY, Prins GS, Abern MR. Estrogens and prostate cancer. Prostate Cancer Prostatic Dis. 2019;22(2):185\u201394.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"3046_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41585-022-00686-y","volume":"20","author":"R Kumar","year":"2023","unstructured":"Kumar R, Sena LA, Denmeade SR, Kachhap S. The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications. Nat Rev Urol. 2023;20(5):265\u201378.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"3046_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.eururo.2018.07.024","volume":"74","author":"EL Watts","year":"2018","unstructured":"Watts EL, Appleby PN, Perez-Cornago A, et al. Low free testosterone and prostate Cancer risk: A collaborative analysis of 20 prospective studies. Eur Urol. 2018;74(5):585\u201394.","journal-title":"Eur Urol"},{"issue":"2 Pt 2","key":"3046_CR33","first-page":"S30","volume":"171","author":"MS Lucia","year":"2004","unstructured":"Lucia MS, Torkko KC. Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale. J Urol. 2004;171(2 Pt 2):S30\u20135.","journal-title":"J Urol"},{"key":"3046_CR34","doi-asserted-by":"publisher","first-page":"1358416","DOI":"10.3389\/fendo.2024.1358416","volume":"15","author":"X Hao","year":"2024","unstructured":"Hao X, Ren C, Zhou H, Li M, Zhang H, Liu X. Association between Circulating immune cells and the risk of prostate cancer: a Mendelian randomization study. Front Endocrinol (Lausanne). 2024;15:1358416. Published 2024 Feb 9.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3046_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ijc.32718","volume":"147","author":"E Stikbakke","year":"2020","unstructured":"Stikbakke E, Richardsen E, Knutsen T, et al. Inflammatory serum markers and risk and severity of prostate cancer: the PROCA-life study. Int J Cancer. 2020;147(1):84\u201392.","journal-title":"Int J Cancer"},{"issue":"12","key":"3046_CR36","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/ijc.28313","volume":"133","author":"AT Toriola","year":"2013","unstructured":"Toriola AT, Laukkanen JA, Kurl S, Nyyss\u00f6nen K, Ronkainen K, Kauhanen J. Prediagnostic Circulating markers of inflammation and risk of prostate cancer. Int J Cancer. 2013;133(12):2961\u20137.","journal-title":"Int J Cancer"},{"issue":"6","key":"3046_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3109\/10409238.2015.1091804","volume":"50","author":"AE Rose","year":"2015","unstructured":"Rose AE, Brown RS, Schlieker C. Torsins: not your typical AAA\u2009+\u2009ATPases. Crit Rev Biochem Mol Biol. 2015;50(6):532\u201349.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"3046_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21(2):71\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3046_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41585-022-00649-3","volume":"19","author":"CM de la Calle","year":"2022","unstructured":"de la Calle CM, Shee K, Yang H, Lonergan PE, Nguyen HG. The Endoplasmic reticulum stress response in prostate cancer. Nat Rev Urol. 2022;19(12):708\u201326.","journal-title":"Nat Rev Urol"},{"issue":"439","key":"3046_CR40","doi-asserted-by":"publisher","first-page":"eaat3975","DOI":"10.1126\/scitranslmed.aat3975","volume":"10","author":"C Logothetis","year":"2018","unstructured":"Logothetis C, Aparicio A, Thompson TC. ER stress in prostate cancer: a therapeutically exploitable vulnerability? Sci Transl Med. 2018;10(439):eaat3975.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3046_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/nu10081021","volume":"10","author":"C Kim","year":"2018","unstructured":"Kim C, Kim B. Anti-Cancer natural products and their bioactive compounds inducing ER Stress-Mediated apoptosis: a review. Nutrients. 2018;10(8):1021.","journal-title":"Nutrients"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03046-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:24:32Z","timestamp":1751361872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03046-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3046"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03046-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All data in this study are from online databases and therefore do not involve ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"1199"}}